American Society of Hematology

SHERPA: Blue

People

  1. Giralt
    Giralt
  2. Zelenetz
    Zelenetz
  3. Levine
    Levine
  4. Tallman
    Tallman
  5. Perales
    Perales
  6. O'Reilly
    O'Reilly
  7. Horwitz
    Horwitz
  8. Devlin
    Devlin
  9. Kernan
    Kernan
  10. Abdel-Wahab
    Abdel-Wahab

Groups

  1. Department of Medicine (3847)
  2. Hematologic Malignancies, Division of (3642)
  3. Center for Hematologic Malignancies (3544)
  4. GSK Faculty (1553)
  5. Adult Leukemia (1290)
  6. Sloan Kettering Institute Faculty (1065)
  7. Bone Marrow Transplant (936)
  8. Center for Molecular Imaging and Biotechnology (CMIB) (931)
  9. Lymphoma (899)
  10. Tow Center for Developmental Oncology (TCDO) (863)
Search Within
Formats
  1. Meeting Abstract (3939)
  2. Journal Article (1242)
  3. Research Letter (44)
  4. Review (44)
  5. Editorial (34)
  6. Guidelines (13)
  7. Correspondence (7)
  8. Miscellaneous (3)
Groups
  1. Department of Medicine (3847)
  2. Hematologic Malignancies, Division of (3642)
  3. Center for Hematologic Malignancies (3544)
  4. GSK Faculty (1553)
  5. Adult Leukemia (1290)
  6. Sloan Kettering Institute Faculty (1065)

More Groups

People
  1. Sergio Giralt (337)
  2. Andrew Zelenetz (328)
  3. Ross Levine (312)
  4. Martin Tallman (298)
  5. Miguel-Angel Perales (292)
  6. Richard O'Reilly (281)

More People

Years
  1. 2025 (46)
  2. 2024 (217)
  3. 2023 (478)
  4. 2022 (369)
  5. 2021 (284)
  6. 2020 (261)

More Years

Publications
  1. Blood (4954)
  2. Blood Advances (322)
  3. Hematology-American Society of Hematology Education Program (50)

Results (5326)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Risk-adapted therapy in adults with Burkitt lymphoma: Preliminary report of a multicenter prospective phase II study of DA-EPOCH-R
    Meeting Abstract

    Dunleavy, K.; Noy, A.; Abramson, J. S.; LaCasce, A. S.; Link, B. K.; Parekh, S.; Jagadeesh, D.; Bierman, P. J.; Mitsuyasu, R. T.; Battini, R.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • PD-1 blockade with pembrolizumab in patients with classical Hodgkin lymphoma after brentuximab vedotin failure: Safety, efficacy, and biomarker assessment
    Meeting Abstract

    Armand, P.; Shipp, M. A.; Ribrag, V.; Michot, J. M.; Zinzani, P. L.; Gutierrez, M.; Snyder, E.; Ricart, A. D.; Balakumaran, A.; Moskowitz, C. H.
    Blood (2015)

    Fulltext@MSK | Save
  • Disruptive ARID1A mutations in follicular lymphoma impair DNA repair efficiency and are associated with favorable outcome in patients receiving first-line immunochemotherapy
    Meeting Abstract

    Bararia, D.; Heide, M.; Welner, R. S.; Romashova, T.; Pastore, A.; Mathur, R.; Gascoyne, R. D.; Kridel, R.; Willson, B. G.; Roberts, C. W. M.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • A chromatin reader that acts as a key to lock in and coordinate recruitment of transcription factors and a novel polycomb complex to bivalent chromatin thus driving formation of germinal centers and B-cell lymphomas
    Meeting Abstract

    Beguelin, W.; Teater, M.; Corcoran, C.; Hamline, M.; Gascoyne, R. D.; Levine, R. L.; Abdel-Wahab, O.; Shaknovich, R.; Elemento, O.; Bardwell, V. J.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Somatic mutations in MDS patients are associated with clinical features and predict prognosis independent of the IPSS-R: Analysis of combined datasets from the International Working Group for Prognosis in MDS-Molecular Committee
    Meeting Abstract

    Bejar, R.; Papaemmanuil, E.; Haferlach, T.; Garcia-Manero, G.; Maciejewski, J. P.; Sekeres, M. A.; Walter, M. J.; Graubert, T. A.; Cazzola, M.; Malcovati, L.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Genomic and proteomic analysis of primary chemoresistance and induction failure in acute myeloid leukemia
    Meeting Abstract

    Brown, F.; Still, E.; Cifani, P.; Ficarro, S.; Pouliot, G.; Drill, E.; Gonen, M.; He, J.; Balasubramanian, S.; Zhong, S.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Presence of PD-1 expressing T cells predicts for inferior overall survival in newly diagnosed multiple myeloma
    Meeting Abstract

    Gasmi, B.; Smith, E. L.; Dogan, A.; Hsu, M.; Devlin, S.; Pichardo, J. D.; Chung, D. J.; Koehne, G.; Korde, N. S.; Landau, H. J.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Predictors of early death in childhood acute promyelocytic leukemia: Results of an international retrospective study
    Meeting Abstract

    Abla, O.; Ribeiro, R. C.; Testi, A. M.; Fernandez, P. M.; Creutzig, U.; Sung, L. L.; Di Giuseppe, G.; Stephens, D.; Hasle, H.; Kaspers, G. J. L.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • BET inhibitor CPI-0610 is well tolerated and induces responses in diffuse large B-cell lymphoma and follicular lymphoma: Preliminary analysis of an ongoing phase 1 study
    Meeting Abstract

    Abramson, J. S.; Blum, K. A.; Flinn, I. W.; Gutierrez, M.; Goy, A.; Maris, M.; Cooper, M.; O'Meara, M.; Borger, D.; Mertz, J.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Nivolumab in patients (Pts) with relapsed or refractory classical Hodgkin lymphoma (R/R cHL): Clinical outcomes from extended follow-up of a phase 1 study (CA209-039)
    Meeting Abstract

    Ansell, S.; Armand, P.; Timmerman, J. M.; Shipp, M. A.; Garelik, M. B. B.; Zhu, L. L.; Lesokhin, A. M.
    Blood (2015)

    Fulltext@MSK | Save